跳至主要内容
临床试验/IRCT20160713028901N4
IRCT20160713028901N4招募中2 期

The effect of selenium supplementation on lipid profile, anemia and inflammation indices in patients undergoing peritoneal dialysis: A placebo-controlled clinical trial

Esfahan University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients undergoing peritoneal dialysis over 18 years of age
  • At least three months have passed since the first dialysis session
  • Satisfied with the study

排除标准

  • Having active hepatitis (according to several studies, selenium levels decrease in patients with hepatitis B and C)
  • Normal serum selenium levels
  • Taking steroidal and non-steroidal anti-inflammatory drugs within two months before the start of the study
  • Take selenium supplements within two months of starting the study
  • Insufficient incompatibility to consume the product

研究者

相似试验